Mercer Global Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Buy |
11,674
+1,560
| +15% | +$49.2K | ﹤0.01% | 1708 |
|
|
2025
Q1 | $331K | Sell |
10,114
-65
| -0.6% | -$2.13K | ﹤0.01% | 1709 |
|
|
2024
Q4 | $368K | Sell |
10,179
-921
| -8% | -$33.3K | ﹤0.01% | 1626 |
|
|
2024
Q3 | $355K | Sell |
11,100
-293
| -3% | -$9.38K | ﹤0.01% | 1534 |
|
|
2024
Q2 | $305K | Sell |
11,393
-720
| -6% | -$19.3K | ﹤0.01% | 1566 |
|
|
2024
Q1 | $413K | Buy |
12,113
+811
| +7% | +$27.7K | ﹤0.01% | 1387 |
|
|
2023
Q4 | $327K | Sell |
11,302
-46
| -0.4% | -$1.33K | ﹤0.01% | 1557 |
|
|
2023
Q3 | $313K | Sell |
11,348
-136
| -1% | -$3.75K | ﹤0.01% | 1510 |
|
|
2023
Q2 | $345K | Buy |
11,484
+1,068
| +10% | +$32.1K | ﹤0.01% | 1428 |
|
|
2023
Q1 | $377K | Buy |
10,416
+263
| +3% | +$9.52K | ﹤0.01% | 1367 |
|
|
2022
Q4 | $362K | Sell |
10,153
-2,571
| -20% | -$91.7K | ﹤0.01% | 1398 |
|
|
2022
Q3 | $431K | Buy |
12,724
+510
| +4% | +$17.3K | ﹤0.01% | 1202 |
|
|
2022
Q2 | $353K | Buy |
12,214
+32
| +0.3% | +$925 | ﹤0.01% | 1344 |
|
|
2022
Q1 | $394K | Buy |
12,182
+2,342
| +24% | +$75.7K | ﹤0.01% | 1362 |
|
|
2021
Q4 | $287K | Buy |
9,840
+315
| +3% | +$9.19K | ﹤0.01% | 1490 |
|
|
2021
Q3 | $254K | Sell |
9,525
-312
| -3% | -$8.32K | ﹤0.01% | 1499 |
|
|
2021
Q2 | $303K | Buy |
+9,837
| New | +$303K | ﹤0.01% | 1383 |
|